Only thing I can add is the following from the 6/6 announcement
"completed in 3Q CY2019. Finally, Phase 1b BTX 1308 psoriasis mechanism of action study is nearing completion with data anticipated to be available in 2Q CY2019. Pipeline projects that leverage the anti-microbial properties of cannabidiol are also moving forward and are planned to enter the clinic in 2H 2019"
Ann: BTX 1801 Kills Superbugs Without Resistance World-First, page-467
-
- There are more pages in this discussion • 156 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.010(2.70%) |
Mkt cap ! $662.1M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 38.0¢ | 36.5¢ | $644.0K | 1.738M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 172425 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 182450 | 10 |
View Market Depth
| Last trade - 12.48pm 07/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |